compound glp 1 side effects Compounded GLP-1s: Why doctors worry and the FDA is cracking down The GLP-1 Side Effect Tracker:
Description
The incidence of severe hypoglycemia in patients with type 2 diabetes was 5% at 26 weeks in patients receiving TOUJEO as part of a multiple daily injection regimen, and 1.0% and 0.9% respectively at 26 weeks in the two studies where patients received TOUJEO as part of a basal-insulin only regimen
Multiple randomized trials are ongoing
An earlier study pointed in the same direction
You might be wondering why your morning cup of green tea isnt helping you drop some pounds
Ojima A, Ishibashi Y, Matsui T, et al
Production capacity constraints with injectable biologics
